Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2013 Financial Results
Date:11/6/2013

an alternative to GAAP measures. 

"We are pleased with the overall momentum of the business and are delighted to deliver what we consider to be a strong third quarter of record revenues in addition to significant non-GAAP earnings per share growth," said Adrian Adams, Chief Executive Officer and President of Auxilium.  "The recent in-licensing of  STENDRA™, a first line oral therapy for erectile dysfunction, further  reflects a  successful execution of our corporate development and licensing strategy which remains focused on diversifying and strengthening our product portfolio. This, together with the potential opportunity for XIAFLEX in Peyronie's disease, if approved by the FDA, and measured progress in research and development with the initiation of a Phase 2a study in cellulite and pending initiation of a Phase 2b study in frozen shoulder later this year positions us well, we believe, to drive increased shareholder value over time."

Third Quarter 2013 and Recent Highlights:

  • On October 23, 2013, Auxilium announced the first cohort of patients has been dosed in its Phase 2a study of collagenase clostridium histolyticum (or "CCH") for the treatment of edematous fibrosclerotic panniculopathy ("EFP), commonly known as cellulite, following positive results observed in earlier open-label studies.
  • On October 11, 2013, Auxilium announced the signing of an agreement with VIVUS, Inc. (Nasdaq: VVUS) providing Auxilium with the exclusive right to market VIVUS's product, STENDRA (avanafil), in the United States and Canada.  STENDRA is an oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of erectile dysfunction. 
  • In September, Auxilium announced it entered into an Incremental Assumption Agreement ("Incremental Agreement") with Morgan Stanley Senior Funding, Inc. ("MSSF") unde
    '/>"/>

  • SOURCE Auxilium Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
    2. Auxilium Pharmaceuticals to Announce First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10, 2012
    3. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
    4. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
    5. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
    6. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
    7. Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results
    8. Auxilium Pharmaceuticals to Announce Third Quarter 2012 Results and Conduct Conference Call on Wednesday, November 7, 2012
    9. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
    10. Auxilium Pharmaceuticals, Inc. Announces Offering of Convertible Senior Notes Due 2018
    11. Auxilium Pharmaceuticals, Inc. Announces Pricing of $325.0 Million of 1.50% Convertible Senior Notes Due 2018
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2014)... July 31, 2014  Zacks.com announces the list of stocks ... Research analysts discuss the latest news and events impacting stocks ... include the Biogen (Nasdaq: BIIB - Free Report ), Gilead ... PBYI - Free Report ), AbbVie (NYSE: ABBV ... Free Report ). Today, Zacks is promoting its ...
    (Date:7/31/2014)... YORK , July 31, 2014 TB ... better, faster and affordable treatments for tuberculosis (TB), announced ... Vice President, Market Access. Ms. Robertson joins the organization ... company,s business in Sub-Saharan Africa and Eastern ... oversee the TB Alliance,s efforts to ensure beneficial new ...
    (Date:7/31/2014)... und KISSING, Deutschland, 31. Juli ... und Distributor eines computerunterstützten („robotischen") Koloskopie-Systems für ... (Homi) Shamir , ein weltweit anerkannter Manager ... und Kontrollgremiums zum Unternehmen stößt. ... Shamir ist ein hochangesehener globaler Visionär ...
    Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 3The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 5The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 6TB Alliance Names Elana Robertson Senior Vice President, Market Access 2TB Alliance Names Elana Robertson Senior Vice President, Market Access 3invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 2invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 3
    ... 4, 2011 Bioness Inc. today ... of the FASTEST study to further examine the impact of ... drop as a result of stroke. The FASTEST study aims ... System over standard therapy with an ankle-foot orthosis (AFO), and ...
    ... Inc. (NASDAQ: NBIX ) today announced that it ... for elagolix and next-generation Gonadotropin Releasing Hormone (GnRH) Receptor Antagonists. ... with the FDA, the outcome of which generated a $20 ... event brings the total milestones achieved by the Company in ...
    Cached Medicine Technology:Bioness Inc. Announces Completion of Enrollment in Its FASTEST L300 Study 2Neurocrine Biosciences Receives Second Milestone Payment of $20 Million Under Abbott Collaboration Agreement 2
    (Date:7/31/2014)... July 31, 2014 Two Moms in ... three new products including: a Cacao Nib Nut Bar, Green ... Moms in the Raw products, each is 100% organic, gluten-free, ... is picky, so I’m constantly working on creating the best-tasting, ... healthy and tasty choices,” said Shari Leidich, Founder and VP ...
    (Date:7/31/2014)... Shiitakes have been called “The workhorse of the ... Sauce below, they cook up in 5-10 minutes. They ... deep flavor -- four to ten times that of ... they're cooked with, so they add variety. They have ... are rich in fiber and contain a fat-absorbing compound ...
    (Date:7/31/2014)... advocated in the United States, a new study suggests ... favorably, people share implicit hierarchies for racial, religious, and ... explicit attitudes and values. , The study findings appear ... Association for Psychological Science. , "People from relatively low-status ... have the most power. At the same time, ...
    (Date:7/31/2014)... New Delhi, India (PRWEB) July 31, 2014 ... company, has launched a new service named ‘Remove Bad ... against which bad reviews are published on various review ... study about the world of internet marketing, the sites ... by its competitors in order to tailor the service. ...
    (Date:7/31/2014)... The Beryl Institute announces three new members ... four new members of its Patient Experience Advisory ... community of practice and premier thought leader on improving ... members are industry leaders who advise on strategy, growth ... market and industry trends. The advisory board provides input ...
    Breaking Medicine News(10 mins):Health News:Two Moms in the Raw Launches Three New, Raw, Sprouted 100% Organic Snacks 2Health News:Two Moms in the Raw Launches Three New, Raw, Sprouted 100% Organic Snacks 3Health News:Quick Fixin’ Summertime Meals with Shiitake Mushrooms -- Bring ‘em Home and Grow Your Own 2Health News:Quick Fixin’ Summertime Meals with Shiitake Mushrooms -- Bring ‘em Home and Grow Your Own 3Health News:Research reveals pervasive implicit hierarchies for race, religion, and age 2Health News:Reputation Management India Launches a New Service Called ‘Remove Bad Reviews’ 2Health News:The Beryl Institute Announces Seven New Patient Experience Board Members 2Health News:The Beryl Institute Announces Seven New Patient Experience Board Members 3
    ... first-ever genetic link to the reason African-Americans are at increased ... researchers at the University of Alabama at Birmingham (UAB) is ... testing. In the study, African-Americans with a Pro72 protein variant ... advanced form of colon cancer compared to whites, the researchers ...
    ... The Kroger Co. said today it is recalling Kroger Lite ... SEP-25-09 sold in Kroger stores in Southwestern Ohio, including Cincinnati and ... may be contaminated with Salmonella. No illnesses have been reported in ... , , , ...
    ... 31 LifeCare Holdings, Inc. (the "Company") today announced its ... 31, 2008. Three Months Ended December 31, ... patient service revenue of $94.2 million for the three months ... to the same period in 2007 while patient days were ...
    ... With the economy in a decline, many healthcare facilities are providing ... , ... (Vocus) March 31, 2009 -- Faced with ... money by relying on dependable professionally refurbished medical equipment ...
    ... Tenn., March 31 ProAssurance Corporation (NYSE: ... Podiatry Insurance Company of America (PICA) have overwhelmingly approved the ... into ProAssurance as a standalone subsidiary. ... domiciliary state of Illinois , is ...
    ... BSX ) announced today that the Court of ... Company,s stent litigation with Johnson and Johnson (J&J). The ... Bx Velocity and Cypher Stent Systems infringe Boston Scientific,s patent ... reversed the District Court with respect to the TAXUS Liberte ...
    Cached Medicine News:Health News:LifeCare Holdings, Inc. Announces Year-End Results 2Health News:LifeCare Holdings, Inc. Announces Year-End Results 3Health News:LifeCare Holdings, Inc. Announces Year-End Results 4Health News:LifeCare Holdings, Inc. Announces Year-End Results 5Health News:LifeCare Holdings, Inc. Announces Year-End Results 6Health News:LifeCare Holdings, Inc. Announces Year-End Results 7Health News:LifeCare Holdings, Inc. Announces Year-End Results 8Health News:LifeCare Holdings, Inc. Announces Year-End Results 9Health News:LifeCare Holdings, Inc. Announces Year-End Results 10Health News:LifeCare Holdings, Inc. Announces Year-End Results 11Health News:LifeCare Holdings, Inc. Announces Year-End Results 12Health News:LifeCare Holdings, Inc. Announces Year-End Results 13Health News:LifeCare Holdings, Inc. Announces Year-End Results 14Health News:LifeCare Holdings, Inc. Announces Year-End Results 15Health News:Healthcare Facilities Focusing on Affordability, Dependability 2Health News:Healthcare Facilities Focusing on Affordability, Dependability 3Health News:PICA Policyholders Approve ProAssurance Transaction 2Health News:PICA Policyholders Approve ProAssurance Transaction 3Health News:PICA Policyholders Approve ProAssurance Transaction 4Health News:PICA Policyholders Approve ProAssurance Transaction 5Health News:PICA Policyholders Approve ProAssurance Transaction 6Health News:Appeals Court Affirms That J&J Stents Infringe Boston Scientific Patent; Claims Against TAXUS Liberte Dismissed 2Health News:Appeals Court Affirms That J&J Stents Infringe Boston Scientific Patent; Claims Against TAXUS Liberte Dismissed 3
    ... System is a long term, quality solution ... in both posterior stabilized and anatomically correct ... provides the flexibility needed to address patients' ... of identification keeps the user in mind ...
    ... Virtual Fluoroscopy software from ... has incorporated ease of ... features such as multiplanar ... models of image guided ...
    ... GE's surgical navigation ... first system to integrate ... tracking technology. It features ... fluoroscopic image to the ...
    The ZEPHIR Anterior Cervical Plate System is the lowest profile plate clinically available....
    Medicine Products: